FTC About to Let Through a ‘Killer Acquisition’

In this Capitol Forum report, the merger of Roche and Spark Therapeutics, which could squash a cure for hemophilia while allowing Roche’s medication for it to thrive, is poised to be approved.

by

TAP depends on your support

We’ve said it before: The greatest threat to democracy from the media isn’t disinformation, it’s the paywall. When you support The American Prospect, you’re supporting fellow readers who aren’t able to give, and countering the class system for information. Please, become a member, or make a one-time donation, today. Thank you!